Next Article in Journal
Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen
Next Article in Special Issue
Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype
Previous Article in Journal
Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood
Previous Article in Special Issue
A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(18), 4506; https://doi.org/10.3390/cancers14184506
Action Date Notes Link
article xml file uploaded 17 September 2022 10:18 CEST Original file -
article xml uploaded. 17 September 2022 10:18 CEST Update -
article pdf uploaded. 17 September 2022 10:19 CEST Version of Record https://www.mdpi.com/2072-6694/14/18/4506/pdf-vor
article supplementary file uploaded. 17 September 2022 10:19 CEST - https://www.mdpi.com/2072-6694/14/18/4506#supplementary
article html file updated 17 September 2022 10:20 CEST Original file -
article xml file uploaded 20 September 2022 07:42 CEST Update -
article xml uploaded. 20 September 2022 07:42 CEST Update -
article pdf uploaded. 20 September 2022 07:42 CEST Updated version of record https://www.mdpi.com/2072-6694/14/18/4506/pdf-vor
article html file updated 20 September 2022 07:43 CEST Update -
article html file updated 20 September 2022 07:58 CEST Update -
article xml file uploaded 20 September 2022 08:44 CEST Update -
article xml uploaded. 20 September 2022 08:44 CEST Update https://www.mdpi.com/2072-6694/14/18/4506/xml
article pdf uploaded. 20 September 2022 08:44 CEST Updated version of record https://www.mdpi.com/2072-6694/14/18/4506/pdf
article html file updated 20 September 2022 08:46 CEST Update https://www.mdpi.com/2072-6694/14/18/4506/html
Back to TopTop